TABLE 1.

CHANGES TO ARRAY FEATURES BY TREATMENT WITH PRAVASTATIN AND MβCD

Cell Type	Comparison	Significant Array Features at p < 0.001 (Corrected Using Benjamini and Hochberg Method for Multiple Testing)	Features Greater Than Twofold Change
MDA-MB-231	Pravastatin relative to control	101	35
MDA-MB-231	MβCD relative to control	79	34
MDA-MB-231	Pravastatin relative to MβCD	27	8
Calu-1	Pravastatin relative to control	2,013	393
Calu-1	MβCD relative to control	3,149	742
Calu-1	Pravastatin relative to MβCD	30	4